tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Immix Biopharma, Inc. (IMMX)
NASDAQ:IMMX
US Market
IMMX
Immix Biopharma, Inc.
Overview
Financials
Dividends
Technical Analysis
Options
Chart
Ownership
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Immix Biopharma, Inc. (IMMX) Stock News & Sentiment

Compare
132 Followers
Buy Rating for Immix Biopharma: Promising Clinical Advancements and Market Potential of NXC-201
Premium
Ratings
Buy Rating for Immix Biopharma: Promising Clinical Advancements and Market Potential of NXC-201
13d ago
IMMX
Immix Biopharma Shareholders Back Growth and Governance Changes
Premium
Company Announcements
Immix Biopharma Shareholders Back Growth and Governance Changes
8M ago
8K
IMMX
Immix Biopharma Announces New Offering, Sparks Investor Interest
Premium
Company Announcements
Immix Biopharma Announces New Offering, Sparks Investor Interest
1y ago
8K
IMMX
Immix Biopharma Signs Definitive $15M Titan Partnership Deal
Premium
Company Announcements
Immix Biopharma Signs Definitive $15M Titan Partnership Deal
1y ago
8K
IMMX
Immix Biopharma Suspends Stock Offering Pending New Prospectus
Premium
Company Announcements
Immix Biopharma Suspends Stock Offering Pending New Prospectus
1y ago
8K
IMMX
Immix Biopharma Blasts Up On Drug Testing News
Premium
Market News
Immix Biopharma Blasts Up On Drug Testing News
2y ago
IMMX
Immix Pops After “In-Licensing” Cancer Cell Therapy
Premium
Market News
Immix Pops After “In-Licensing” Cancer Cell Therapy
2y ago
IMMX
More IMMX News >

IMMX News on the Web

Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis
Yahoo Finance
Neutral
Several Insiders Invested In Immix Biopharma Flagging Positive News
Yahoo Finance
Neutral
Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort Dose Level in U.S. AL Amyloidosis Trial NEXICART-2
Yahoo Finance
Neutral
Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board
Yahoo Finance
Neutral
Immix Biopharma Independent Director Acquires 2.6% More Stock
Yahoo Finance
Neutral
Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2
Yahoo Finance
Neutral
What Makes Immix Biopharma a New Buy Stock
Yahoo Finance
Neutral
What Makes Immix Biopharma (IMMX) a New Buy Stock
Zacks
Bullish

News Score - Last 7 Days

Neutral
IMMX
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMMX’s Media Buzz Sentiment?
Currently, no data Available
What is IMMX’s weekly average amount of articles?
Currently, no data Available
What is IMMX’s News Sentiment?
50% of articles about IMMX were positive this week, compared to its sector average of 57%.
    Healthcare Stocks that are Trending in the News
    HCMHUTCHMED
    PENPenumbra
    AMNAMN Healthcare Services
    BNTCBenitec Biopharma
    IMUXImmunic
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing